Microfluidic in vivo screen identifies compounds enhancing neuronal regeneration

Area of Science:

• Neuroscience
• Biotechnology
• Pharmacology

Background:

• Compound screening is vital for discovering therapeutic targets and understanding biological mechanisms.
• Neuronal regeneration remains a significant challenge in treating neurological disorders.

Purpose of the Study:

• To report the first in vivo small-molecule screens for compounds that enhance neuronal regeneration.
• To introduce novel microfluidic devices for high-throughput screening in C. elegans.

Main Methods:

• Development of microfluidic devices for rapid and repeatable immobilization of C. elegans.
• Performing high-throughput and precise surgical procedures on C. elegans within microfluidic devices.
• Exposing C. elegans to small-molecule libraries post-surgery and assaying for neuronal regeneration.

Main Results:

• Identification of several small-molecule compounds that significantly enhance neuronal regeneration in vivo.
• Demonstration of the efficacy of microfluidic devices for in vivo compound screening.
• Establishment of a novel platform for discovering regenerative therapies.

Conclusions:

• The developed microfluidic screening platform is effective for identifying compounds that promote neuronal regeneration.
• This approach accelerates the discovery of potential therapeutic agents for nerve repair.
• Further investigation of identified compounds may lead to new treatments for neurological injuries and diseases.